MedTrace Logo

Effect of Probiotic Supplement in Alleviating Functional Gastrointestinal Symptoms

NCT01728610 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 391

Last updated 2016-01-26

No results posted yet for this study

Summary

The purpose of this study is to analyse the effect of a probiotic supplement on functional intestinal symptoms among subjects diagnosed with irritable bowel syndrome (IBS).

Conditions

  • Irritable Bowel Syndrome

Interventions

DIETARY_SUPPLEMENT

Probiotic (Active high)

Higher dose of probiotic supplement

DIETARY_SUPPLEMENT

Probiotic (Active low)

Lower dose of probiotic supplement

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • Danisco

    lead INDUSTRY

Principal Investigators

  • Lea Veijola, MD · Herttoniemi Hospital

  • Arthur Ouwehand, PhD · DuPont Nutrition and Health

  • Sampo Lahtinen, PhD · DuPont Nutrition and Health

  • Anna Lyra, PhD · DuPont Nutrition and Health

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01728610 on ClinicalTrials.gov